vs
Kimball Electronics, Inc.(KE)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
Kimball Electronics, Inc.的季度营收约是REPLIGEN CORP的1.7倍($341.3M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs 1.1%,领先5.6%),REPLIGEN CORP同比增速更快(13.6% vs -4.5%),REPLIGEN CORP自由现金流更多($17.6M vs $-11.2M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -10.4%)
金伯尔国际是一家美国企业,旗下拥有金伯尔、国民、Interwoven等多个家具品牌,业务涵盖酒店家具等多元产品线。它的前身是19至20世纪一度成为全球最大钢琴与管风琴制造商的W.W.金伯尔公司,如今转型聚焦商用家具领域发展。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
KE vs RGEN — 直观对比
营收规模更大
KE
是对方的1.7倍
$197.9M
营收增速更快
RGEN
高出18.2%
-4.5%
净利率更高
RGEN
高出5.6%
1.1%
自由现金流更多
RGEN
多$28.8M
$-11.2M
两年增速更快
RGEN
近两年复合增速
-10.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $341.3M | $197.9M |
| 净利润 | $3.6M | $13.3M |
| 毛利率 | 8.2% | 52.5% |
| 营业利润率 | 3.2% | 9.0% |
| 净利率 | 1.1% | 6.7% |
| 营收同比 | -4.5% | 13.6% |
| 净利润同比 | 6.0% | 143.9% |
| 每股收益(稀释后) | $0.15 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KE
RGEN
| Q4 25 | $341.3M | $197.9M | ||
| Q3 25 | $365.6M | $188.8M | ||
| Q2 25 | $380.5M | $182.4M | ||
| Q1 25 | $374.6M | $169.2M | ||
| Q4 24 | $357.4M | $174.1M | ||
| Q3 24 | $374.3M | $154.9M | ||
| Q2 24 | $430.2M | $154.1M | ||
| Q1 24 | $425.0M | $151.3M |
净利润
KE
RGEN
| Q4 25 | $3.6M | $13.3M | ||
| Q3 25 | $10.1M | $14.9M | ||
| Q2 25 | $6.6M | $14.9M | ||
| Q1 25 | $3.8M | $5.8M | ||
| Q4 24 | $3.4M | $-30.3M | ||
| Q3 24 | $3.2M | $-654.0K | ||
| Q2 24 | $7.5M | $3.3M | ||
| Q1 24 | $-6.1M | $2.1M |
毛利率
KE
RGEN
| Q4 25 | 8.2% | 52.5% | ||
| Q3 25 | 7.9% | 53.2% | ||
| Q2 25 | 8.0% | 50.0% | ||
| Q1 25 | 7.2% | 53.6% | ||
| Q4 24 | 6.6% | 26.1% | ||
| Q3 24 | 6.3% | 50.0% | ||
| Q2 24 | 8.5% | 49.8% | ||
| Q1 24 | 7.9% | 49.5% |
营业利润率
KE
RGEN
| Q4 25 | 3.2% | 9.0% | ||
| Q3 25 | 4.0% | 8.9% | ||
| Q2 25 | 4.3% | 7.6% | ||
| Q1 25 | 3.1% | 3.9% | ||
| Q4 24 | 2.3% | -17.7% | ||
| Q3 24 | 2.4% | -5.1% | ||
| Q2 24 | 4.6% | 1.0% | ||
| Q1 24 | -1.5% | 1.3% |
净利率
KE
RGEN
| Q4 25 | 1.1% | 6.7% | ||
| Q3 25 | 2.8% | 7.9% | ||
| Q2 25 | 1.7% | 8.2% | ||
| Q1 25 | 1.0% | 3.4% | ||
| Q4 24 | 1.0% | -17.4% | ||
| Q3 24 | 0.8% | -0.4% | ||
| Q2 24 | 1.8% | 2.2% | ||
| Q1 24 | -1.4% | 1.4% |
每股收益(稀释后)
KE
RGEN
| Q4 25 | $0.15 | $0.24 | ||
| Q3 25 | $0.40 | $0.26 | ||
| Q2 25 | $0.27 | $0.26 | ||
| Q1 25 | $0.15 | $0.10 | ||
| Q4 24 | $0.14 | $-0.55 | ||
| Q3 24 | $0.12 | $-0.01 | ||
| Q2 24 | $0.29 | $0.06 | ||
| Q1 24 | $-0.24 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $767.6M |
| 总债务越低越好 | $153.8M | $542.2M |
| 股东权益账面价值 | $579.2M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
KE
RGEN
| Q4 25 | $77.9M | $767.6M | ||
| Q3 25 | $75.7M | $748.7M | ||
| Q2 25 | $88.8M | $708.9M | ||
| Q1 25 | $51.4M | $697.2M | ||
| Q4 24 | $53.9M | $757.4M | ||
| Q3 24 | $76.6M | $784.0M | ||
| Q2 24 | $78.0M | $809.1M | ||
| Q1 24 | $65.2M | $780.6M |
总债务
KE
RGEN
| Q4 25 | $153.8M | $542.2M | ||
| Q3 25 | $137.5M | $537.9M | ||
| Q2 25 | $147.1M | — | ||
| Q1 25 | $178.3M | — | ||
| Q4 24 | $204.5M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | $294.8M | — | ||
| Q1 24 | — | — |
股东权益
KE
RGEN
| Q4 25 | $579.2M | $2.1B | ||
| Q3 25 | $577.1M | $2.1B | ||
| Q2 25 | $569.9M | $2.1B | ||
| Q1 25 | $548.1M | $2.0B | ||
| Q4 24 | $537.5M | $2.0B | ||
| Q3 24 | $547.8M | $2.0B | ||
| Q2 24 | $540.5M | $2.0B | ||
| Q1 24 | $539.1M | $2.0B |
总资产
KE
RGEN
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.2B | $2.9B | ||
| Q1 24 | $1.3B | $2.8B |
负债/权益比
KE
RGEN
| Q4 25 | 0.27× | 0.26× | ||
| Q3 25 | 0.24× | 0.26× | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.38× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $6.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.2M | $17.6M |
| 自由现金流率自由现金流/营收 | -3.3% | 8.9% |
| 资本支出强度资本支出/营收 | 5.3% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.89× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $81.8M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
KE
RGEN
| Q4 25 | $6.9M | $25.7M | ||
| Q3 25 | $8.1M | $48.1M | ||
| Q2 25 | $78.1M | $28.6M | ||
| Q1 25 | $30.9M | $15.0M | ||
| Q4 24 | $29.5M | $39.2M | ||
| Q3 24 | $45.5M | $49.3M | ||
| Q2 24 | $48.5M | $42.2M | ||
| Q1 24 | $42.6M | $44.7M |
自由现金流
KE
RGEN
| Q4 25 | $-11.2M | $17.6M | ||
| Q3 25 | $-2.5M | $43.4M | ||
| Q2 25 | $68.4M | $21.5M | ||
| Q1 25 | $27.0M | $11.4M | ||
| Q4 24 | $23.1M | $33.6M | ||
| Q3 24 | $32.1M | $42.3M | ||
| Q2 24 | $39.5M | $37.4M | ||
| Q1 24 | $30.0M | $36.4M |
自由现金流率
KE
RGEN
| Q4 25 | -3.3% | 8.9% | ||
| Q3 25 | -0.7% | 23.0% | ||
| Q2 25 | 18.0% | 11.8% | ||
| Q1 25 | 7.2% | 6.8% | ||
| Q4 24 | 6.5% | 19.3% | ||
| Q3 24 | 8.6% | 27.3% | ||
| Q2 24 | 9.2% | 24.3% | ||
| Q1 24 | 7.1% | 24.0% |
资本支出强度
KE
RGEN
| Q4 25 | 5.3% | 4.1% | ||
| Q3 25 | 2.9% | 2.5% | ||
| Q2 25 | 2.5% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 1.8% | 3.2% | ||
| Q3 24 | 3.6% | 4.5% | ||
| Q2 24 | 2.1% | 3.1% | ||
| Q1 24 | 3.0% | 5.5% |
现金转化率
KE
RGEN
| Q4 25 | 1.89× | 1.93× | ||
| Q3 25 | 0.80× | 3.23× | ||
| Q2 25 | 11.86× | 1.92× | ||
| Q1 25 | 8.11× | 2.57× | ||
| Q4 24 | 8.58× | — | ||
| Q3 24 | 14.42× | — | ||
| Q2 24 | 6.43× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KE
| Automotive | $162.3M | 48% |
| Medical | $96.3M | 28% |
| Industrial | $82.7M | 24% |
RGEN
暂无分部数据